ADAMTS13 ACTIVITY INCREASED

This adverse event was reported 8 times

These drugs are most commonly taken by patients reporting ADAMTS13 ACTIVITY INCREASED:

# Drug Count
0 CAPLACIZUMAB 4
1 APADAMTASE ALFA 1
2 METHYLPREDNISOLONE 1
3 OBINUTUZUMAB 1
4 RAVULIZUMAB 1
5 RITUXIMAB 1
See all common drugs associated with ADAMTS13 ACTIVITY INCREASED

ADAMTS13 ACTIVITY INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 APADAMTASE ALFA 1 0.0127
1 CAPLACIZUMAB 4 0.0022
2 OBINUTUZUMAB 1 0.0001
3 METHYLPREDNISOLONE 1 0.0000
4 RITUXIMAB 1 0.0000
See all drugs enriched for association with ADAMTS13 ACTIVITY INCREASED

These drug classes are most commonly taken by patients reporting ADAMTS13 ACTIVITY INCREASED:

# Drug class Count
0 CD20-directed Cytolytic Antibody [EPC] 1
1 Corticosteroid [EPC] 1
See all common drug classes associated with ADAMTS13 ACTIVITY INCREASED

ADAMTS13 ACTIVITY INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
1 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with ADAMTS13 ACTIVITY INCREASED